Jyong Biotech (MENS) Debt Ratio (2024 - 2025)
Jyong Biotech's Debt Ratio was 0.47 in the quarter ended Dec 31, 2025, down 67.6% from 1.46 a year earlier.
Powered by 
Analysis
Jyong Biotech (MENS) Debt Ratio (2024 - 2025) Analysis & Trends
- In earlier years, Debt Ratio was 1.46 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Jyong Biotech | 155.86 Mn | 155.86 Mn | - | 0.47 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.47 |
| Jun 30, 2025 | 0.66 |
| Dec 31, 2024 | 1.46 |
API Access
Jyong Biotech Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=MENS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "MENS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=MENS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();